Failure of Risk Assessment After Paracetamol Overdose—A Short Communication

*Laboratoire de Pharmacologie, Toxicologie et Gaz du Sang, CHU de Saint Etienne, France;

†Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver; and

‡Department of Emergency Medicine and Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.

Correspondence: Manon Launay, PharmD, PhD, Laboratoire de Pharmacologie, Toxicologie, Gaz du Sang, Plateau de Biologie, Hôpital Nord—CHU Saint Etienne, 42055 Saint Etienne, France (e-mail: [email protected]).

The data that support the findings of this study are available from the corresponding author on reasonable request.

O. Boussetta-Charfi, B. H. Rumack, and M. Launay conceived and designed the analysis. O. Boussetta-Charfi, C. F. D'Andon, and M. Launay contributed to data collection. O. Boussetta-Charfi, H. Nguyen, and M. Launay performed data analysis. All authors wrote, revised, and accepted the final version of the paper.

The authors declare no conflict of interest.

This study was approved by the Institutional Review Board (IRBN1442021/CHUSTE).

留言 (0)

沒有登入
gif